Jun 22, 2026 04:44PM
Jun 22, 2026 04:43PM
May 13, 2026 04:01PM
May 11, 2026 05:22PM
May 11, 2026 05:20PM
Apr 8, 2026 04:30PM
Apr 8, 2026 04:30PM FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study
Mar 10, 2026 05:03PM
Mar 9, 2026 04:01PM
Feb 24, 2026 04:29AM
Feb 23, 2026 06:14PM
Nov 12, 2025 04:01PM
Aug 14, 2025 04:01PM
Aug 13, 2025 04:01PM MacroGenics names Eric Risser as CEO, replacing 24-year leader
Aug 13, 2025 04:01PM
Aug 13, 2025 04:01PM
Aug 13, 2025 04:01PM
May 13, 2025 04:01PM
Mar 20, 2025 04:02PM
Nov 5, 2024 04:01PM
Oct 30, 2024 07:30AM Macrogenics (MGNX) Announces CEO Departure
Oct 30, 2024 07:30AM
Oct 22, 2024 07:30AM
Oct 22, 2024 07:30AM
Dec 19, 2023 05:30PM
Nov 6, 2023 04:01PM
Aug 9, 2023 04:01PM
May 9, 2023 04:01PM MacroGenics Provides Update on Corporate Progress and First Quarter 2023 Financial Results
Mar 22, 2023 01:23PM
Mar 22, 2023 01:22PM
Mar 22, 2023 01:22PM
Mar 15, 2023 04:01PM
Nov 18, 2022 05:16AM
Nov 17, 2022 06:10PM
Nov 17, 2022 06:10PM MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab
Nov 3, 2022 04:01PM
Aug 8, 2022 04:01PM
Jul 8, 2022 04:38PM
Jul 8, 2022 04:30PM
Jul 8, 2022 04:30PM
May 3, 2022 04:01PM
Feb 24, 2022 04:01PM MacroGenics Provides Update on Corporate Progress and 2021 Financial Results
Feb 24, 2022 04:01PM
Nov 2, 2021 04:01PM
Sep 16, 2021 05:47AM
Sep 16, 2021 02:45AM
Sep 16, 2021 02:45AM
Sep 7, 2021 04:34PM
Sep 7, 2021 04:30PM MacroGenics Announces Final Overall Survival Results from SOPHIA Study of MARGENZA™ in Patients with HER2-Positive Metastatic Breast Cancer
Sep 7, 2021 04:30PM

323,915 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All